Evidence map›Paper›PMID 30970547›Full record

ReviewToxins2019

Roles of Shiga Toxins in Immunopathology.

Moo-Seung Lee, Vernon L Tesh

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Virulence and Antimicrobial Resistance Traits ofAntibiotics (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Shiga toxin-producing Escherichia coli infection-related acute encephalopathy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  14. Review
  15. Shiga Toxins Produced by EnterohaemorrhagicJournal of microbiology and biotechnology · 2024
    Article
  16. Article
  17. Article
  18. Safety Properties ofFoods (Basel, Switzerland) · 2023
    Review
  19. Review
  20. Recent Advancements in Technologies to Detect EnterohaemorrhagicJournal of microbiology and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Moo-Seung LeeEnvironmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Daejeon 34141, Korea. msl031000@kribb.re.kr.
Vernon L TeshDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807, USA. tesh@medicine.tamhsc.edu.
Korea University of Science and Technology · KRTexas A&M Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsGastrointestinal DiseasesHemolytic-Uremic SyndromeHumansImmunity, InnateKidney DiseasesShiga ToxinsShiga Toxinsbacterial toxinshemolytic uremic syndromeimmunopathologyShiga toxin-producing Escherichia coliShiga toxinsShiga toxin types 1 and 2

Identifiers

PMID30970547
PMCPMC6521259
OpenAlexW2936815238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.